Published on 25 Mar 2024 on Simply Wall St. via Yahoo Finance
Insiders who bought US$396.8k worth of Vicarious Surgical Inc.'s (NYSE:RBOT) stock at an average buy price of US$2.19 over the last year may be disappointed by the recent 11% decrease in the stock. Insiders purchase with the hope of seeing their investments increase in value over time. However, due to recent losses, their initial investment is now only worth US$61.9k, which is not great.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.
View our latest analysis for Vicarious Surgical